N@N

Mani Foroohar Maintained (ALNY) at Hold with Increased Target to $98 on, Jun 15th, 2022

Mani Foroohar of SVB Leerink, Maintained "Alnylam Pharmaceuticals, Inc." (ALNY) at Hold with Increased Target from $96 to $98 on, Jun 15th, 2022.

Mani has made no other calls on ALNY in the last 4 months.

There are 5 other peers that have a rating on ALNY. Out of the 5 peers that are also analyzing ALNY, 2 agree with Mani's Rating of Hold. Following are those relevant analyst calls for the last 4 months

---

• Gary Nachman of "BMO Capital" Maintained at Hold with Decreased Target to $166 on, Friday, April 29th, 2022
• Matthew Harrison of "Morgan Stanley" Maintained at Hold with Decreased Target to $170 on, Friday, April 29th, 2022

These are the ratings of the 3 analyists that currently disagree with Mani

---

• Myles Minter of "William Blair" Initiated at Buy on, Tuesday, June 7th, 2022
• Patrick Trucchio of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $430 on, Monday, May 2nd, 2022
• David Lebowitz of "Citigroup" Maintained at Strong Buy with Decreased Target to $211 on, Friday, April 29th, 2022

Contributing Sources

---